Schizophrenia Bulletin Advance Access originally published online on February 25, 2009
Schizophrenia Bulletin 2009 35(2):297-298; doi:10.1093/schbul/sbn188
© The Author 2009. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.
Atypical Antipsychotics for People With Both Schizophrenia and Depression
Vivek A Furtado1,2,
Vinod Srihari3 and
Ajit Kumar4
2 Health Policy, Planning and Finance, London School of Hygiene and Tropical Medicine and London School of Economics, Keppel Street, London WC1E 7HT, UK
3 Department of Psychiatry, Yale School of Medicine, New Haven, CT
4 Leeds Mental Health National Health Service Trust, St James University Hospital, Leeds, UK
| The first 10% of the full text of this article appears below. |
 |
Background
|
|---|
Many people (up to 50%) with schizophrenia also have comorbid
depression. It has been suggested that new atypical antipsychotic
drugs are beneficial for people with the 2 diagnoses.
 |
Objectives
|
|---|
To assess the effects of atypical antipsychotic drugs on people
who
. . . [Full Text of this Article]
 |
Search Strategy
|
|---|
 |
Selection Criteria
|
|---|
 |
Data Collection and Analysis
|
|---|
 |
Main Results
|
|---|
 |
Authors Conclusions
|
|---|
1 To whom correspondence should be addressed; tel: 0044 113 30 55000, fax: 0044 113 30 55339, e-mail: vivek.furtado@LSHTM.ac.uk.

CiteULike
Connotea
Del.icio.us What's this?